Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y015834 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y013575 | — |
No additional AE; Product Lot number issue; was given on 8/13/2025; an adult patient received PROQUAD; This spontaneous report was received from a pharmacist and refers to a 33-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-Jul-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013575, expiration date: 03-Feb-2026) 1 dosage form with sterile diluent (Hollister-Stier STERILE DILUENT) (Product administered to patient of inappropriate age). On 13-Aug-2025, the patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) with sterile diluent (Hollister-Stier STERILE DILUENT), (lot #Y015834 (invalid for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) but valid for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II)), product lot issue), expiration date: 20-Sep-2026) 1 dosage form (Expiration Date was also reported as 02-SEP-2026) (Inappropriate schedule of product administration). All were of prophylaxis. No additional events (no adverse event).
Sterile Diluent